Please go to the PowerPak homepage
and select a course.
HIV Snippets: A Podcast Series
This continuing education activity is provided by Vindico Medical Education
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
November 30, 2020
November 29, 2021
The intended audience for this activity is infectious disease specialists, internists, pharmacists, and other health care professionals involved in the management of patients with HIV.
Upon successful completion of this activity, participants should be better able to:
- Interpret recent guideline revisions regarding the use of antiretroviral therapy (ART) in different patient populations.
- Examine current and prospective use of 2-drug regimens in the treatment of HIV.
- Incorporate individualized ART regimens to improve outcomes in patients with HIV and comorbidities.
- Utilize ART regimens that improve outcomes in highly treatment-experienced patients with HIV.
- Examine the potential use of long-acting injectable ART formulations in patients with HIV who struggle with stigma and/or adherence to prescribed regimens.
- Evaluate practice-based advances that may improve the consistent use of pre-exposure prophylaxis (PrEP).
Richard A. Elion, MD
Director of Clinical Research
Washington Health Institute
Clinical Professor of Medicine
George Washington University School of Medicine
Speakers Bureau: Gilead, ViiV
Contracted Research (paid to institution): Gilead, Merck, ViiV
Scientific Advisory Board: Gilead, ViiV
Raphael J. Landovitz, MD, MSc
Professor of Medicine
Co-Director, UCLA Center for Clinical AIDS Research & Education
University of California, Los Angeles
Los Angeles, CA
Advisory Board: Gilead, Merck
Chloe Orkin, MBBCh, FRCP
Consultant Physician, Barts Health NHS Trust
Clinical Lead for COVID 19 Research at Barts Health NHS Trust
Lead for HIV and HIV/Hep C Research
Athena Swan Chair, Queen Mary University of London School of Medicine
London, United Kingdom
Speakers Bureau: Gilead, GlaxoSmithKline, Merck, ViiV
Contracted Research: Gilead, GlaxoSmithKline, Merck, ViiV
Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP
Contracted Research (paid to institution): ViiV
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education Staff
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already-diverse field of HIV treatment. In this CE activity, participants will listen to expert faculty in a series of 6 podcasts. The faculty of this program will explore various aspects of HIV management, including recent guideline revisions, use of 2-drug regimens, individualizing ART regimens in patients with HIV and comorbidities, as well as the management of patients with HIV who are highly treatment-experienced. In addition, the potential use of long-acting injectable ART formulations in patients with HIV who struggle with stigma and/or adherence as well as advances in pre-exposure prophylaxis are examined.
In accordance with the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears above.
Vindico Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This program is acceptable for 1.50 contact hour of ACPE Continuing Education Credit. The ACPE Universal Program Number 0482-0000-20-013-H02-P, effective 11/30/2020. This is a knowledge-based activity and there is no fee to attend.
This enduring material is approved for 1 year from the date of original release, November 30, 2020 to November 29, 2021.
How to Participate in This Activity and Obtain CPE Credit
During the period November 30, 2020 to November 29, 2021, participants must 1) read the learning objectives and faculty disclosures; 2) complete the pre-survey; 3) study the educational activity; and 4) complete the posttest and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. To answer the questions, click on your selected choice for each answer then proceed to the next question. You must answer 4 out of 6 posttest questions correctly to achieve a passing score. Once completed, click on the Grade Exam button at the bottom of the page. Your posttest will automatically be graded. Your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.
For downloadable educational resources, visit below.
For a full list of all the educational tools available through Vindico Medical Education, please visit: www.VindicoCME.com/educationaltools
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Contact us at CME@VindicoCME.com